Intramyocardial Hemorrhage and the “Wave Front” of Reperfusion Injury Compromising Myocardial Salvage
Original Investigation
Central Illustration
Abstract
Background
Reperfusion therapy for acute myocardial infarction (MI) is lifesaving. However, the benefit of reperfusion therapy can be paradoxically diminished by reperfusion injury, which can increase MI size.
Objectives
Hemorrhage is known to occur in reperfused MIs, but whether hemorrhage plays a role in reperfusion-mediated MI expansion is not known.
Methods
We studied cardiac troponin kinetics (cTn) of ST-segment elevation MI patients (n = 70) classified by cardiovascular magnetic resonance to be hemorrhagic (70%) or nonhemorrhagic following primary percutaneous coronary intervention. To isolate the effects of hemorrhage from ischemic burden, we performed controlled canine studies (n = 25), and serially followed both cTn and MI size with time-lapse imaging.
Results
CTn was not different before reperfusion; however, an increase in cTn following primary percutaneous coronary intervention peaked earlier (12 hours vs 24 hours; P < 0.05) and was significantly higher in patients with hemorrhage (P < 0.01). In hemorrhagic animals, reperfusion led to rapid expansion of myocardial necrosis culminating in epicardial involvement, which was not present in nonhemorrhagic cases (P < 0.001). MI size and salvage were not different at 1 hour postreperfusion in animals with and without hemorrhage (P = 0.65). However, within 72 hours of reperfusion, a 4-fold greater loss in salvageable myocardium was evident in hemorrhagic MIs (P < 0.001). This paralleled observations in patients with larger MIs occurring in hemorrhagic cases (P < 0.01).
Conclusions
Myocardial hemorrhage is a determinant of MI size. It drives MI expansion after reperfusion and compromises myocardial salvage. This introduces a clinical role of hemorrhage in acute care management, risk assessment, and future therapeutics.
References
1. "Heart disease and stroke statistics-2020 update: a report from the American Heart Association". Circulation 2020;141:e139-e596.
2. "Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction". JAMA 2000;283:2941-2947.
3. "Myocardial reperfusion injury". N Engl J Med 2007;357:1121-1135.
4. "Myocardial reperfusion: a double-edged sword?"J Clin Invest 1985;76:1713-1719.
5. "Myocardial ischemia-reperfusion injury: a neglected therapeutic target". J Clin Invest 2013;123:92-100.
6. "Dynamic progression of contractile and endothelial dysfunction and infarct extension in the late phase of reperfusion". J Surg Res 2000;94:133-144.
7. "A fresh look at reperfusion injury". Cardiovasc Res 1998;38:291-300.
8. "Effect of cyclosporine on reperfusion injury in acute myocardial infarction". N Engl J Med 2008;359:473-481.
9. "Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial". Circulation 2013;128:1495-1503.
10. "Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction". Eur Heart J 2012;33:1491-1499.
11. "Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial". Lancet 2010;375:727-734.
12. "Cyclosporine before PCI in patients with acute myocardial infarction". N Engl J Med 2015;373:1021-1031.
13. "Early intravenous beta-blockers in patients with ST-segment elevation myocardial infarction before primary percutaneous coronary intervention". J Am Coll Cardiol 2016;67:2705-2715.
14. "Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2/ERIC-PPCI): a single-blind randomised controlled trial". Lancet 2019;394:1415-1424.
15. "A post hoc analysis of long-term prognosis after exenatide treatment in patients with ST-segment elevation myocardial infarction". EuroIntervention 2016;12:449-455.
16. "Targeting Myocardial Reperfusion Injury--The Search Continues". N Engl J Med 2015;373:1073-1075.
17. "The “no-reflow” phenomenon after temporary coronary occlusion in the dog". J Clin Invest 1974;54:1496-1508.
18. "Magnetic resonance imaging-defined areas of microvascular obstruction after acute myocardial infarction represent microvascular destruction and haemorrhage". Eur Heart J 2013;34:2346-2353.
19. "Effect of coronary reperfusion on myocardial hemorrhage and infarct healing". Am J Cardiol 1983;52:610-614.
20. "Temporal evolution of myocardial hemorrhage and edema in patients after acute ST-segment elevation myocardial infarction: pathophysiological insights and clinical implications". J Am Heart Assoc 2016;5:2: e002834. https://doi.org/10.1161/JAHA.115.002834.
21. "Prognostic value and determinants of a hypointense infarct core in T2-weighted cardiac magnetic resonance in acute reperfused ST-elevation-myocardial infarction". Circ Cardiovasc Imaging 2011;4:354-362.
22. "Microvascular reperfusion injury: rapid expansion of anatomic no reflow during reperfusion in the rabbit". Am J Physiol Heart Circ Physiol 2002;283:H1099-H1107.
23. "Intramyocardial haemorrhage after acute myocardial infarction". Nat Rev Cardiol 2015;12:156-167.
24. "The “wavefront phenomenon” of myocardial ischemic cell death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow". Lab Invest 1979;40:633-644.
25. "Cardiac protection during acute myocardial infarction: where do we stand in 2004?"J Am Coll Cardiol 2004;44:276-286.
26. "Clinical benefit of early reperfusion therapy in patients with ST-elevation myocardial infarction usually excluded from randomized clinical trials (results from the Maximal Individual Therapy in Acute Myocardial Infarction Plus [MITRA Plus] registry)". Am J Cardiol 2009;104:1074-1077.
27. "Extended mortality benefit of early postinfarction reperfusion. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries Trial". Circulation 1998;97:1549-1556.
28. "Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials". Lancet 2003;361:13-20.
29. "Reperfusion strategies in acute ST-segment elevation myocardial infarction: a comprehensive review of contemporary management options". J Am Coll Cardiol 2007;50:917-929.
30. "Incidence, predictors, and prognostic value of intramyocardial hemorrhage lesions in ST elevation myocardial infarction". Catheter Cardiovasc Interv 2012;79:1101-1108.
